ArticlePloS one2007
Sharing detailed research data is associated with increased citation rate.
Article in PloS one, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
192 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Keeping the promise: a critique of the current state of microdosing research.Frontiers in psychiatry · 2024Pooled it
- Identifying the most important facilitators of open research data sharing and reuse in Epidemiology: A mixed-methods study.PloS one · 2024Pooled it
- Prevalence and predictors of data and code sharing in the medical and health sciences: systematic review with meta-analysis of individual participant data.BMJ (Clinical research ed.) · 2023Pooled it
- The impact of institutional repositories: a systematic review.Journal of the Medical Library Association : JMLA · 2020Pooled it
- Pooled it
- CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.Trials · 2018Guideline
- Data sharing statements: impact of journal policies across clinical research disciplines.European heart journal · 2026Article
- Anonymization and visualization of health data and biomarkers.NPJ digital medicine · 2026Article
- Article
- Insights and priorities from the 2025 private funders' Parkinson's disease and related disorders large footprint data interoperability summit.Journal of Parkinson's disease · 2026Article
- Ten quick tips for using the NIH Comparative Genomics Resource.PLoS computational biology · 2026Article
- Making human derived data FAIR: feedback from NCI office of data sharing workshop.Journal of the National Cancer Institute · 2025Article
- Digital neuropathology of neurodegenerative disorders: Foundations, research advances, and future directions.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Review
- From policy to practice: progress towards data- and code-sharing in ecology and evolution.Proceedings. Biological sciences · 2025Article
- Retrospective analysis and decentralized distribution to improve the lifecycle of Ah receptor research assets.Biochemical pharmacology · 2025Article
- SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials.BMJ (Clinical research ed.) · 2025Article
- FAIR data for optical tweezers experiments.Biophysical journal · 2025Review
- The academic impact of Open Science: a scoping review.Royal Society open science · 2025Review
- How will we prepare for an uncertain future? The value of open data and code for unborn generations facing climate change.Proceedings. Biological sciences · 2025Article
- Data accessibility in the chemical sciences: an analysis of recent practice in organic chemistry journals.Beilstein journal of organic chemistry · 2025Article
132 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundSharing research data provides benefit to the general scientific community, but the benefit is less obvious for the investigator who makes his or her data available. PRINCIPAL
findingsWe examined the citation history of 85 cancer microarray clinical trial publications with respect to the availability of their data. The 48% of trials with publicly available microarray data received 85% of the aggregate citations. Publicly available data was significantly (p = 0.006) associated with a 69% increase in citations, independently of journal impact factor, date of publication, and author country of origin using linear regression. SIGNIFICANCE: This correlation between publicly available data and increased literature impact may further motivate investigators to share their detailed research data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.